| Name | Pack Size |
| Artificial Canine Saliva or Simulated Canine Saliva (BZ297) | 100 mL,200mL,500mL,1000mL |
| Artificial Human Saliva BZ323 | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva AFNOR NF S91-141 | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva BZ319 | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva for Drug testing & Research | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva for Food Products Testing (BZ463) | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva BZ326 | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva for Pharmaceutical Research | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva Mucin Added BZ389 | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva Mucin Added BZ390 as per ASTM E2720-16/ASTM E2721-16 | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva or Synthetic Saliva BZ324 | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva with a-Amylase Added BZ400 | 100 mL,200mL,500mL,1000mL |
| Artificial Saliva with Cortisol (BZ411) | 100 mL,200mL,500mL,1000mL |
| Artificial Sublingual Saliva BZ432 | 100 mL,200mL,500mL,1000mL |
| DIN 53160-1:2010-10 Artificial Saliva | 100 mL,200mL,500mL,1000mL |
| DIN 53160:2023-07 Compliant Saliva Simulant | 100 mL,200mL,500mL,1000mL |
| Fusayama/Meyer Artificial Saliva | 100 mL,200mL,500mL,1000mL |
| Human Oral Fluid Substitute " data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Biochemazone品牌全系列产品"> 艾美捷科技代理Biochemazone品牌全系列产品
...
阅读详情
  Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。 DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California. Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha. The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs. <<
更多详情请联系 艾美捷科技有限公司 全国服务热线：400-6800-868 邮箱：sales@amyjet.com 网站：www.amyjet.com
" data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Dendritics"> Dendritics
...
阅读详情
地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：17754422825
传真：13212737804
邮箱：sales@amyjet.com
0.1932
|
<
